Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 3, 2004, Pages 852-859

  Paris, Caroline ^a   Loiseau, Philippe M ^a   Bories, Christian ^a   Bréard, Jaqueline ^b  

^a UNIVERSITÉ PARIS SUD   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID DERIVATIVE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; DNA FRAGMENT; KETONE DERIVATIVE; MILTEFOSINE; PHOSPHATIDYLSERINE; PROTEINASE INHIBITOR;

ANTIPROTOZOAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; DRUG POTENCY; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; ANTIPROTOZOAL AGENTS; APOPTOSIS; CELL CYCLE; CHROMATOGRAPHY, AGAROSE; COLORIMETRY; DNA FRAGMENTATION; FLOW CYTOMETRY; LEISHMANIA DONOVANI; PHOSPHATIDYLSERINES; PHOSPHORYLCHOLINE; PROTEASE INHIBITORS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 1442349131     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.3.852-859.2004     Document Type: Article

References (69)

1. Ameisen, J. C. 1995. Apoptosis in a unicellular eukaryotes (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell in the control of cell proliferation, differentiation and survival. Cell Death Differ. 2:285-300.
2. Ameisen, J. C. 2002. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 9:367-393.
3. Aravind, L., V. M. Dixit, and E. V. Koonin. 2001. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291:1279-1284.
4. Arnoult, D., K. Akarid, A. Grodet, P. X. Petit, J. Estaquier, and J. C. Ameisen. 2002. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 9:65-81.
5. Boggs, K., C. O. Rock, and S. Jackowski. 1998. The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine. Biochim. Biophys. Acta 1389:1-12.
6. Cornillon, S., C. Foa, J. Davoust, N. Buonavista, J. D. Gross, and P. Golstein. 1994. Programmed cell death in Dictyostelium. J. Cell Sci. 107:2691-2704.
7. Croft, S. L., R. A. Neal, W. Pendergast, and J. H. Chan. 1987. The activity of alkylphosphocholines and related derivatives against Leishmania donovani. Biochem. Pharmacol. 36:2633-2636.
8. Croft, S. L., D. Snowdon, and V. Yardley. 1996. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J. Antimicrob. Chemother. 38:1041-1047.
9. Das, M., S. B. Mukherjee, and C. Shaha. 2001. Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes. J. Cell Sci. 114: 2461-2469.
10. Davis, M. C., J. G. Ward, G. Herrick, and C. D. Allis. 1992. Programmed nuclear death: apoptotic-like degradation of specific nuclei in conjugating Tetrahymena. Dev. Biol. 154:419-432.
11. Desjeux, P. 1996. Leishmaniasis. Public health aspects and control. Clin. Dermatol. 14:417-423.
12. + deprivation. J. Neurochem. 70:1809-1818.
13. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50.
14. Engelmann, J., J. Henke, W. Willker, B. Kutscher, G. Nossner, J. Engel, and D. Leibfritz. 1996. Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. Anticancer Res. 16:1429-1439.
15. 3 (edelfosine) and amphotericin B. Acta Trop. 81:151-157.
16. Escobar, P., V. Yardley, and S. L. Croft. 2001. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrob. Agents Chemother. 45:1872-1875.
17. Garcia-Calvo, M., E. P. Peterson, B. Leiting, R. Ruel, D. W. Nicholson, and N. A. Thornberry. 1998. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273:32608-32613.
18. Geilen, C. C., T. Wieder, A. Haase, W. Reutter, D. M. Morre, and D. J. Morre. 1994. Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells. Biochim. Biophys. Acta 1211:14-22.
19. Geilen, C. C., T. Wieder, and W. Reutter. 1992. Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells. J. Biol. Chem. 267:6719-6724.
20. Guerin, P. J., P. Olliaro, S. Sundar, M. Boelaert, S. L. Croft, P. Desjeux, P., M. K. Wasunna, and A. D. Bryceson. 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect. Dis. 2:494-501.
21. Haase, R., T. Wieder, C. C. Geilen, and W. Reutter. 1991. The phospholipid analogue hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells. FEBS Lett. 288:129-132.
22. Henke, J., J. Engelmann, U. Flögel, J. Pfeuffer, B. Kutscher, G. Nobner, J. Engel, R. Voegeli, and D. Leibfritz. 1999. Apoptotic effects of hexadecylphosphocholine on resistant and non-resistant cells monitored by NMR spectroscopy. Drugs Today 34:37-50.
23. 13C NMR-spectroscopy. Anticancer Res. 19:4027-4032.
24. Holzmuller, P., D. Sereno, M. Cavaleyrz, I. Mangot, S. Daulouede, P. Vincendeau, and J. L. Lemesre. 2002. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect. Immun. 70:3727-3735.
25. Jha, T. K., S. Sundar, C. P. Thakur, P. Bachmann, J. Karbwang, C. Fischer, A. Voss, and J. Berman. 1999. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N. Engl. J. Med. 341:1795-1800.
26. Johnson, D. E. 2000. Noncaspase proteases in apoptosis. Leukemia 14:1695-1703.
27. The Joint United Nations Programme on HIV/AIDS. December 2002. AIDS epidemic update. [Online.] http://www.unaids.org.
28. Konstantinov, S. M., R. Kaminsky, R. Brun, M. R. Berger, and U. Zillmann. 1997. Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. Acta Trop. 64:145-154.
29. Kuhlencord, A., T. Maniera, H. Eibl, and C. Unger. 1992. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob. Agents Chemother. 36:1630-1634.
30. Lee, N., S. Bertholet, A. Debradant, J. Muller, R. Duncan, and H. L. Nakhasi. 2002. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 9:53-64.
31. Le Fichoux, Y., D. Rousseau, B. Ferrua, S. Ruette, A. Lelievre, D. Grousson, and J. Kubar. 1998. Short- and long term-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob. Agents Chemother. 42:654-658.
32. Lira, R., L. M. Contreras, R. M. Santa-Rita, and J. A. Urbina. 2001. Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazole. J. Antimicrob. Chemother. 47: 537-546.
33. Lux, H., D. T. Hart, P. J. Parker, and T. Klenner. 1996. Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues. Adv. Exp. Med. Biol. 416:201-211.
34. Lux, H., N. Heise, T. Klenner, D. Hart, and F. R. Opperdoes. 2000. Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania. Mol. Biochem. Parasitol. 111:1-14.
35. Moreira, M. E., H. A. Del Portillo, R. V. Milder, J. M. Balanco, and M. A. Barcinski. 1996. Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis. J. Cell. Physiol. 167:305-313.
36. Mottram, J. C., M. J. Helms, G. H. Coombs, and M. Sajid. 2003. Clan CD cysteine peptidases of parasitic protozoa. Trends Parasitol. 19:182-187.
37. 2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J. Biol. Chem. 277:24717-24727.
38. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279.
39. Paredes, R., J. Munoz, I. Diaz, P. Domingo, M. Gurgui, and B. Clotet. 2003. Leismaniasis in HIV infection. J. Postgrad. Med. 49:39-49.
40. Paugam, A., A. L. Bulteau, J. Dupouy-Camet, C. Creuzet, and B. Friguet. 2003. Characterization and role of protozoan parasite proteasomes. Trends Parasitol. 19:55-59.
41. Raff, M. C. 1992. Social controls on cell survival and cell death. Nature 356:397-400.
42. 2+-dependent cell death pathway in the unicellular organism Trypanosoma brucei brucei. Biochem. J. 340:33-40.
43. Ruiter, G. A., M. Verheij, S. F. Zerp, and W. J. Van Blitterswijk. 2001. Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis. Int. J. Radiat. Oncol. Biol. Phys. 49:415-419.
44. Ruiter, G. A., S. F. Zerp, H. Bartelink, W. J. Van Blitterswijk, and M. Verheij. 1999. Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res. 59:2457-2463.
45. Rybczynska, M., M. Spitaler, N. G. Knebel, G. Boeck, H. Grunicke, and J. Hofmann. 2001. Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities. Biochem. Pharmacol. 62:765-772.
46. Santa-Rita, R. M., H. Santos Barbosa, M. N. Meirelles, and S. L. De Castro. 2000. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi. Acta Trop. 75:219-228.
47. Saraiva, V. B., D. Gibaldi, J. O. Previato, L. Mendonça-Previato, M. T. Bozza, C. G. Freire-De-Lima, and N. Heise. 2002. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi. Antimicrob. Agents Chemother. 46: 3472-3477.
48. Seifert, K., M. Duchene, W. H. Wernsdorfer, H. Kollaritsch, O. Scheiner, G. Wiedermann, T. Hottkowitz, and H. Eibl. 2001. Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob. Agents Chemother. 45:1505-1510.
49. Seifert, K., S. Matu, F. J. Pérez-Victoria, S. Castanys, F. Gamarro, and S. L. Croft. 2003. Characterization of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int. J. Antimicrob. Agents 22:380-387.
50. Sereno, D., P. Holzmuller, I. Mangot, G. Cuny, A. Ouaissi, and J. L. Lemesre. 2001. Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob. Agents Chemother. 45:2064-2069.
51. Soto, J., J. Toledo, P. Gutierrez, R. S. Nicholls, J. Padilla, J. Engel, C. Fischer, A. Voss, and J. Berman. 2001. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin. Infect. Dis. 33:E57-E61.
52. Sundar, S. 2001. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 6:849-854.
53. Sundar, S., L. B. Gupta, M. K. Makharia, M. K. Singh, A. Voss, F. Rosenkaimer, J. Engel, and H. W. Murray. 1999. Oral treatment of visceral leishmaniasis with miltefosine. Ann. Trop. Med. Parasitol. 93:589-597.
54. Sundar, S., A. Makharia, D. K. More, G. Agrawal, A. Voss, C. Fischer, P. Bachmann, and H. W. Murray. 2000. Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin. Infect. Dis. 31:1110-1113.
55. Sundar, S., F. Rosenkaimer, M. K. Makharia, A. K. Goyal, A. K. Mandal, A. Voss, P. Hilgard, and H. W. Murray. 1998. Trial of oral miltefosine for visceral leishmaniasis. Lancet 352:1821-1823.
56. Szallies, A., B. K. Kubata, and M. Duszenko. 2002. A metacaspase of Trypanosoma brucei causes loss of respiration competence and clonal death in the yeast Saccharomyces cerevisiae. FEBS Lett. 517:144-150.
57. Thornberry, N. A., and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312-1316.
58. Unger, C., T. Maniera, P. Kaufmann-Kolle, and H. Eibl. 1998. In vivo antileishmanial activity of hexadecylphosphocholine and other alkylphosphocholines. Drugs Today 34:133-140.
59. Unger, C., M. Peukert, H. Sindermann, P. Hilgard, G. Nagel, and H. Eibl. 1990. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Cancer Treat. Rev. 17:243-246.
60. Uren, A. G., K. O'Rourke, L. A. Aravind, M. T. Pisabarro, S. Seshagiri, E. V. Koonin, and V. M. Dixit. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma, Mol. Cell 6:961-967.
61. Van Blitterswijk, W. J., H. Hilkmann, and G. A. Storme. 1987. Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids 22:820-823.
62. 2 limitation and oxidative stress. Curr. Biol. 9:1061-1064.
63. Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. 1995. A novel assay for apoptosis. Flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immunol. Methods 184:39-51.
64. Walochnik, J., M. Duchene, K. Seifert, A. Obwaller, T. Hottkowitz, G. Wiedermann, H. Eibl, and H. Aspock. 2002. Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob. Agents Chemother. 46:695-701.
65. Wang, Y. Z., Y. B. Chang, C. Xing, and D. Fu. 1998. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukaemia cell lines. Int. J. Tissue React. 20:101-107.
66. Welburn, S. C., S. Lillico, and N. B. Murphy. 1999. Programmed cell death in procyclic form Trypanosoma brucei rhodesiense: identification of differentially expressed genes during Con A induced death. Mem. Inst. Oswaldo Cruz 94:229-234.
67. Wieder, T., C. E. Orfanos, and C. C. Geilen. 1998. Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J. Biol. Chem. 273:11025-11031.
68. Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556.
69. Zangger, H., J. C. Mottram, and N. Fasel. 2002. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? Cell Death Differ. 9:1126-1139.